
LINK . SPRINGER . COM {
}
Title:
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers | Breast Cancer Research and Treatment
Description:
A majority of breast cancers are estrogen receptor (ER) positive and have a luminal epithelial phenotype. However, these ER+ tumors often contain heterogeneous subpopulations of ER− tumor cells. We previously identified a population of cytokeratin 5 (CK5) positive cells within ER+ and progesterone receptor positive (PR+) tumors that is both ER−PR− and CD44+, a marker of breast tumor-initiating cells (TICs). These CK5+ cells have properties of TICs in luminal tumor xenografts, and we speculated that they are more resistant to chemo- and anti-ER-targeted therapies than their ER+ neighbors. To test this, we used ER+PR+ T47D and MCF7 breast cancer cells. CK5+ cells had lower proliferative indices than CK5− cells, were less sensitive to 5-fluorouracil and docetaxel, and cultures became enriched for CK5+ cells after treatments. CK5+ cells were less prone to drug-induced apoptosis than CK5− cells. In cells treated with 17β-estradiol (E) plus anti-estrogens tamoxifen or fulvestrant, ER protein levels decreased, and CK5 protein levels increased, compared to controls treated with E alone. In ER+ tumors from patients treated with neoadjuvant endocrine therapies ER gene expression decreased, and CK5 gene expression increased in post compared to pre-treatment tumors. The number of CK5+ cells in tumors also increased in post- compared to pre-treatment tumors. We conclude that an ER−PR−CK5+ subpopulation found in many luminal tumors is resistant to standard endocrine and chemotherapies, relative to the majority ER+PR+CK5− cells. Compounds that effectively target these cells are needed to improve outcome in luminal breast cancers.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Health & Fitness
- Education
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We don’t know how the website earns money.
Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.
Keywords {🔍}
breast, cancer, article, google, scholar, pubmed, cells, cas, receptor, cell, human, res, luminal, tumors, endocrine, stem, therapy, horwitz, estrogen, usa, research, cancers, expression, clin, oncol, cytokeratin, sartorius, tumor, access, resistance, privacy, cookies, content, positive, growth, molecular, natl, prognostic, university, colorado, medical, department, publish, search, steroid, negative, resistant, kabos, haughian, wang,
Topics {✒️}
month download article/chapter er−pr−ck5+ subpopulation found breast tumor-initiating cells majority er+pr+ck5− cells clinical oncology yia-pn200810-161 neoadjuvant endocrine therapy anti-er-targeted therapies tumorigenic breast-cancer cells node-positive breast cancer hormone receptor expression therapy resistant subpopulation tumor-initiating features er− tumor cells breast tumor xenografts full article pdf cd44+/cd24−/low cells anti-estrogens tamoxifen human breast carcinoma luminal breast cancers endocrine therapy residual breast cancers breast tumor heterogeneity breast cancer defined breast cancer subtypes recurrent breast cancer human breast tumours triple-negative phenotype luminal tumor xenografts cancer stem cells privacy choices/manage cookies neoplastic breast cells colorado cancer center primary breast cancers targeted therapies transforms primary breast cancer er+pr+ t47d steroid receptor negative triple-receptor measurements harvell dm progesterone receptor positive estrogen-receptor biology steroid receptor expression 5-bromo-2-deoxyuridine ck cheang mc creighton cj tumour stem cells luminal epithelial phenotype molecular profile subtype perou cm article kabos
Questions {❓}
- O’Brien CS, Howell SJ, Farnie G et al (2009) Resistance to endocrine therapy: are breast cancer stem cells the culprits?
Schema {🗺️}
WebPage:
mainEntity:
headline:Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers
description:A majority of breast cancers are estrogen receptor (ER) positive and have a luminal epithelial phenotype. However, these ER+ tumors often contain heterogeneous subpopulations of ER− tumor cells. We previously identified a population of cytokeratin 5 (CK5) positive cells within ER+ and progesterone receptor positive (PR+) tumors that is both ER−PR− and CD44+, a marker of breast tumor-initiating cells (TICs). These CK5+ cells have properties of TICs in luminal tumor xenografts, and we speculated that they are more resistant to chemo- and anti-ER-targeted therapies than their ER+ neighbors. To test this, we used ER+PR+ T47D and MCF7 breast cancer cells. CK5+ cells had lower proliferative indices than CK5− cells, were less sensitive to 5-fluorouracil and docetaxel, and cultures became enriched for CK5+ cells after treatments. CK5+ cells were less prone to drug-induced apoptosis than CK5− cells. In cells treated with 17β-estradiol (E) plus anti-estrogens tamoxifen or fulvestrant, ER protein levels decreased, and CK5 protein levels increased, compared to controls treated with E alone. In ER+ tumors from patients treated with neoadjuvant endocrine therapies ER gene expression decreased, and CK5 gene expression increased in post compared to pre-treatment tumors. The number of CK5+ cells in tumors also increased in post- compared to pre-treatment tumors. We conclude that an ER−PR−CK5+ subpopulation found in many luminal tumors is resistant to standard endocrine and chemotherapies, relative to the majority ER+PR+CK5− cells. Compounds that effectively target these cells are needed to improve outcome in luminal breast cancers.
datePublished:2010-07-28T00:00:00Z
dateModified:2010-07-28T00:00:00Z
pageStart:45
pageEnd:55
sameAs:https://doi.org/10.1007/s10549-010-1078-6
keywords:
Tumor-initiating cells
Estrogen receptors
Endocrine therapy
Tamoxifen
Cytokeratin 5
Breast cancer
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig6_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:128
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Peter Kabos
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:James M. Haughian
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Xinshuo Wang
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Wendy W. Dye
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Christina Finlayson
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Department of Surgery, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Anthony Elias
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Kathryn B. Horwitz
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:University of Colorado Anschutz Medical Campus
address:
name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Carol A. Sartorius
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers
description:A majority of breast cancers are estrogen receptor (ER) positive and have a luminal epithelial phenotype. However, these ER+ tumors often contain heterogeneous subpopulations of ER− tumor cells. We previously identified a population of cytokeratin 5 (CK5) positive cells within ER+ and progesterone receptor positive (PR+) tumors that is both ER−PR− and CD44+, a marker of breast tumor-initiating cells (TICs). These CK5+ cells have properties of TICs in luminal tumor xenografts, and we speculated that they are more resistant to chemo- and anti-ER-targeted therapies than their ER+ neighbors. To test this, we used ER+PR+ T47D and MCF7 breast cancer cells. CK5+ cells had lower proliferative indices than CK5− cells, were less sensitive to 5-fluorouracil and docetaxel, and cultures became enriched for CK5+ cells after treatments. CK5+ cells were less prone to drug-induced apoptosis than CK5− cells. In cells treated with 17β-estradiol (E) plus anti-estrogens tamoxifen or fulvestrant, ER protein levels decreased, and CK5 protein levels increased, compared to controls treated with E alone. In ER+ tumors from patients treated with neoadjuvant endocrine therapies ER gene expression decreased, and CK5 gene expression increased in post compared to pre-treatment tumors. The number of CK5+ cells in tumors also increased in post- compared to pre-treatment tumors. We conclude that an ER−PR−CK5+ subpopulation found in many luminal tumors is resistant to standard endocrine and chemotherapies, relative to the majority ER+PR+CK5− cells. Compounds that effectively target these cells are needed to improve outcome in luminal breast cancers.
datePublished:2010-07-28T00:00:00Z
dateModified:2010-07-28T00:00:00Z
pageStart:45
pageEnd:55
sameAs:https://doi.org/10.1007/s10549-010-1078-6
keywords:
Tumor-initiating cells
Estrogen receptors
Endocrine therapy
Tamoxifen
Cytokeratin 5
Breast cancer
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1078-6/MediaObjects/10549_2010_1078_Fig6_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:128
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Peter Kabos
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:James M. Haughian
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Xinshuo Wang
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Wendy W. Dye
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Christina Finlayson
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Department of Surgery, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Anthony Elias
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Kathryn B. Horwitz
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:University of Colorado Anschutz Medical Campus
address:
name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
type:Person
name:Carol A. Sartorius
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:128
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
name:University of Colorado Anschutz Medical Campus
address:
name:Department of Surgery, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
name:University of Colorado Anschutz Medical Campus
address:
name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Peter Kabos
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:James M. Haughian
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:Xinshuo Wang
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:Wendy W. Dye
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:Christina Finlayson
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Department of Surgery, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:Anthony Elias
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:Kathryn B. Horwitz
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:University of Colorado Anschutz Medical Campus
address:
name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
name:Carol A. Sartorius
affiliation:
name:University of Colorado Anschutz Medical Campus
address:
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
name:Department of Surgery, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
name:Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
name:Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, USA
name:Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(170)
- Profit of https://www.springernature.com/gp/authors
- Explore the financials of https://link.springernature.com/home/
- What's the revenue for https://order.springer.com/public/cart?
- What's the monthly money flow for https://submission.springernature.com/new-submission/10549/3?
- How much does https://www.springernature.com/gp/librarians/licensing/agc/journals rake in every month?
- Monthly income for https://doi.org/10.1200/JCO.2005.09.004
- What's https://doi.org/10.1200%2FJCO.2005.09.004's gross income?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16234531?
- How much income is http://scholar.google.com/scholar_lookup?&title=Biology%20of%20progesterone%20receptor%20loss%20in%20breast%20cancer%20and%20its%20implications%20for%20endocrine%20therapy&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.09.004&volume=23&pages=7721-7735&publication_year=2005&author=Cui%2CX&author=Schiff%2CR&author=Arpino%2CG earning monthly?
- What's the income generated by https://doi.org/10.1038/35021093 each month?
- What's the profit of https://doi.org/10.1038%2F35021093?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10963602
- How much does http://scholar.google.com/scholar_lookup?&title=Molecular%20portraits%20of%20human%20breast%20tumours&journal=Nature&doi=10.1038%2F35021093&volume=406&pages=747-752&publication_year=2000&author=Perou%2CCM&author=Sorlie%2CT&author=Eisen%2CMB net monthly?
- https://doi.org/10.1200/JCO.2005.04.7985 income
- How much does https://doi.org/10.1200%2FJCO.2005.04.7985 bring in each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16720680 pull in?
- How much income does http://scholar.google.com/scholar_lookup?&title=Gene%20expression%20and%20benefit%20of%20chemotherapy%20in%20women%20with%20node-negative%2C%20estrogen%20receptor-positive%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.04.7985&volume=24&pages=3726-3734&publication_year=2006&author=Paik%2CS&author=Tang%2CG&author=Shak%2CS have?
- What's the monthly money flow for https://doi.org/10.1200%2FJCO.2005.10.036?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15755967?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Estrogen-receptor%20biology%3A%20continuing%20progress%20and%20therapeutic%20implications&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.10.036&volume=23&pages=1616-1622&publication_year=2005&author=Osborne%2CCK&author=Schiff%2CR?
- Learn about the earnings of https://doi.org/10.1038/nrc1590
- Revenue of https://doi.org/10.1038%2Fnrc1590
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15803154?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Tumour%20stem%20cells%20and%20drug%20resistance&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1590&volume=5&pages=275-284&publication_year=2005&author=Dean%2CM&author=Fojo%2CT&author=Bates%2CS bring in?
- What's the financial outcome of https://doi.org/10.1038/nature07733?
- Profit of https://doi.org/10.1038%2Fnature07733
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19194462?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Association%20of%20reactive%20oxygen%20species%20levels%20and%20radioresistance%20in%20cancer%20stem%20cells&journal=Nature&doi=10.1038%2Fnature07733&volume=458&pages=780-783&publication_year=2009&author=Diehn%2CM&author=Cho%2CRW&author=Lobo%2CNA?
- How much income is https://doi.org/10.1073/pnas.0530291100 earning monthly?
- How much does https://doi.org/10.1073%2Fpnas.0530291100 earn?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12629218 earning monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Prospective%20identification%20of%20tumorigenic%20breast%20cancer%20cells&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0530291100&volume=100&pages=3983-3988&publication_year=2003&author=Al-Hajj%2CM&author=Wicha%2CMS&author=Benito-Hernandez%2CA produce monthly?
- What are the earnings of https://doi.org/10.1186/bcr1982?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18366788
- http://scholar.google.com/scholar_lookup?&title=Human%20breast%20cancer%20cell%20lines%20contain%20stem-like%20cells%20that%20self-renew%2C%20give%20rise%20to%20phenotypically%20diverse%20progeny%20and%20survive%20chemotherapy&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr1982&volume=10&publication_year=2008&author=Fillmore%2CCM&author=Kuperwasser%2CC's financial summary
- How much profit does https://doi.org/10.1093/jnci/djn123 make?
- How much does https://doi.org/10.1093%2Fjnci%2Fdjn123 earn?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18445819?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Intrinsic%20resistance%20of%20tumorigenic%20breast%20cancer%20cells%20to%20chemotherapy&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjn123&volume=100&pages=672-679&publication_year=2008&author=Li%2CX&author=Lewis%2CMT&author=Huang%2CJ?
- What's the financial gain of https://doi.org/10.1093%2Fjnci%2Fdjj495?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17179479 earning monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=The%20response%20of%20cd24%28-%2Flow%29%2Fcd44%2B%20breast%20cancer-initiating%20cells%20to%20radiation&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjj495&volume=98&pages=1777-1785&publication_year=2006&author=Phillips%2CTM&author=McBride%2CWH&author=Pajonk%2CF earning monthly?
- Check the income stats for https://doi.org/10.1056/NEJMoa063994
- Income figures for https://doi.org/10.1056%2FNEJMoa063994
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17229949?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20role%20of%20a%20gene%20signature%20from%20tumorigenic%20breast-cancer%20cells&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa063994&volume=356&pages=217-226&publication_year=2007&author=Liu%2CR&author=Wang%2CX&author=Chen%2CGY
- How much does https://doi.org/10.1016/j.ccr.2007.01.013 bring in each month?
- How much money does https://doi.org/10.1016%2Fj.ccr.2007.01.013 generate?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17349583?
- How much does http://scholar.google.com/scholar_lookup?&title=Molecular%20definition%20of%20breast%20tumor%20heterogeneity&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2007.01.013&volume=11&pages=259-273&publication_year=2007&author=Shipitsin%2CM&author=Campbell%2CLL&author=Argani%2CP net monthly?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15709183 is on a monthly basis
- Revenue of http://scholar.google.com/scholar_lookup?&title=Prevalence%20of%20cd44%2B%2Fcd24%E2%88%92%2Flow%20cells%20in%20breast%20cancer%20may%20not%20be%20associated%20with%20clinical%20outcome%20but%20may%20favor%20distant%20metastasis&journal=Clin%20Cancer%20Res&volume=11&pages=1154-1159&publication_year=2005&author=Abraham%2CBK&author=Fritz%2CP&author=McClellan%2CM
- How much revenue does https://doi.org/10.1186/bcr2108 bring in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18559090 gross monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20cd44%2B%2Fcd24%E2%88%92%20phenotype%20is%20enriched%20in%20basal-like%20breast%20tumors&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr2108&volume=10&publication_year=2008&author=Honeth%2CG&author=Bendahl%2CPO&author=Ringner%2CM bring in?
- How much income is https://doi.org/10.1016/j.stem.2007.08.014 earning monthly?
- What's the financial intake of https://doi.org/10.1016%2Fj.stem.2007.08.014?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18371393?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Aldh1%20is%20a%20marker%20of%20normal%20and%20malignant%20human%20mammary%20stem%20cells%20and%20a%20predictor%20of%20poor%20clinical%20outcome&journal=Cell%20Stem%20Cell&doi=10.1016%2Fj.stem.2007.08.014&volume=1&pages=555-567&publication_year=2007&author=Ginestier%2CC&author=Hur%2CMH&author=Charafe-Jauffret%2CE
- https://doi.org/10.1158/0008-5472.CAN-08-2741's financial summary
- https://doi.org/10.1158%2F0008-5472.CAN-08-2741's financial summary
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19190339
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20cell%20lines%20contain%20functional%20cancer%20stem%20cells%20with%20metastatic%20capacity%20and%20a%20distinct%20molecular%20signature&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-2741&volume=69&pages=1302-1313&publication_year=2009&author=Charafe-Jauffret%2CE&author=Ginestier%2CC&author=Iovino%2CF?
- How much does https://doi.org/10.1007/s10911-009-9115-y make?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19252972 makes per month
- How much does http://scholar.google.com/scholar_lookup?&title=Resistance%20to%20endocrine%20therapy%3A%20are%20breast%20cancer%20stem%20cells%20the%20culprits%3F&journal=J%20Mammary%20Gland%20Biol%20Neoplasia&doi=10.1007%2Fs10911-009-9115-y&volume=14&pages=45-54&publication_year=2009&author=O%E2%80%99Brien%2CCS&author=Howell%2CSJ&author=Farnie%2CG earn?
- https://doi.org/10.1073/pnas.0706216105's financial summary
- Revenue of https://doi.org/10.1073%2Fpnas.0706216105
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18391223 gross monthly?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Rare%20steroid%20receptor-negative%20basal-like%20tumorigenic%20cells%20in%20luminal%20subtype%20human%20breast%20cancer%20xenografts&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0706216105&volume=105&pages=5774-5779&publication_year=2008&author=Horwitz%2CKB&author=Dye%2CWW&author=Harrell%2CJC is on a monthly basis
- How much revenue does https://doi.org/10.1038/nm.2000 bring in?
- Profit of https://doi.org/10.1038%2Fnm.2000
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19648928
- See how much http://scholar.google.com/scholar_lookup?&title=Aberrant%20luminal%20progenitors%20as%20the%20candidate%20target%20population%20for%20basal%20tumor%20development%20in%20BRCA1%20mutation%20carriers&journal=Nat%20Med&doi=10.1038%2Fnm.2000&volume=15&pages=907-913&publication_year=2009&author=Lim%2CE&author=Vaillant%2CF&author=Wu%2CD makes per month
- What's the income generated by https://doi.org/10.1046%2Fj.1365-2184.36.s.1.7.x each month?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14521517?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Evidence%20of%20progenitor%20cells%20of%20glandular%20and%20myoepithelial%20cell%20lineages%20in%20the%20human%20adult%20female%20breast%20epithelium%3A%20a%20new%20progenitor%20%28adult%20stem%29%20cell%20concept&journal=Cell%20Prolif&doi=10.1046%2Fj.1365-2184.36.s.1.7.x&volume=36&issue=Suppl%201&pages=73-84&publication_year=2003&author=Boecker%2CW&author=Buerger%2CH?
- What's the financial outcome of https://doi.org/0.1002/path.1241?
- How much does http://scholar.google.com/scholar_lookup?&title=Common%20adult%20stem%20cells%20in%20the%20human%20breast%20give%20rise%20to%20glandular%20and%20myoepithelial%20cell%20lineages%3A%20a%20new%20cell%20biological%20concept&journal=Lab%20Investig&doi=0.1002%2Fpath.1241&volume=82&pages=737-746&publication_year=2002&author=Boecker%2CW&author=Moll%2CR&author=Poremba%2CC pull in?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=228940
- How much does http://scholar.google.com/scholar_lookup?&title=Establishment%20and%20characterization%20of%20a%20cell%20line%20of%20human%20breast%20carcinoma%20origin&journal=Eur%20J%20Cancer&volume=15&pages=659-670&publication_year=1979&author=Keydar%2CI&author=Chen%2CL&author=Karby%2CS generate monthly?
- What is the monthly revenue of https://doi.org/10.1158/0008-5472.CAN-05-0505?
- How much profit does https://doi.org/10.1158%2F0008-5472.CAN-05-0505 make?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16266999
- Profit of http://scholar.google.com/scholar_lookup?&title=Progestins%20initiate%20a%20luminal%20to%20myoepithelial%20switch%20in%20estrogen-dependent%20human%20breast%20tumors%20without%20altering%20growth&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-05-0505&volume=65&pages=9779-9788&publication_year=2005&author=Sartorius%2CCA&author=Harvell%2CDM&author=Shen%2CT
- What is the monthly revenue of https://doi.org/10.1007/s10549-008-9897-4?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18327671 earning monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Molecular%20signatures%20of%20neoadjuvant%20endocrine%20therapy%20for%20breast%20cancer%3A%20characteristics%20of%20response%20or%20intrinsic%20resistance&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-008-9897-4&volume=112&pages=475-488&publication_year=2008&author=Harvell%2CDM&author=Spoelstra%2CNS&author=Singh%2CM
- What are the total earnings of https://doi.org/10.1158/1078-0432.CCR-07-1658?
- What's the monthly income of https://doi.org/10.1158%2F1078-0432.CCR-07-1658?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18316557 make?
- How much income is http://scholar.google.com/scholar_lookup?&title=Basal-like%20breast%20cancer%20defined%20by%20five%20biomarkers%20has%20superior%20prognostic%20value%20than%20triple-negative%20phenotype&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1658&volume=14&pages=1368-1376&publication_year=2008&author=Cheang%2CMC&author=Voduc%2CD&author=Bajdik%2CC earning monthly?
- Check the income stats for https://doi.org/10.1200/JCO.2008.18.1024
- How much money does https://doi.org/10.1200%2FJCO.2008.18.1024 generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19204205 income
- How much does http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20subtypes%20and%20response%20to%20docetaxel%20in%20node-positive%20breast%20cancer%3A%20use%20of%20an%20immunohistochemical%20definition%20in%20the%20bcirg%20001%20trial&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.18.1024&volume=27&pages=1168-1176&publication_year=2009&author=Hugh%2CJ&author=Hanson%2CJ&author=Cheang%2CMC pull in?
- What's the financial gain of https://doi.org/10.1002/path.1559?
- How much income is https://doi.org/10.1002%2Fpath.1559 earning monthly?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15141381?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20luminal%20and%20basal%20cytokeratins%20in%20human%20breast%20carcinoma&journal=J%20Pathol&doi=10.1002%2Fpath.1559&volume=203&pages=661-671&publication_year=2004&author=Abd%20El-Rehim%2CDM&author=Pinder%2CSE&author=Paish%2CCE?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9737789?
- Profit of http://scholar.google.com/scholar_lookup?&title=Biological%20and%20prognostic%20significance%20of%20stratified%20epithelial%20cytokeratins%20in%20infiltrating%20ductal%20breast%20carcinomas&journal=Virchows%20Arch&doi=10.1007%2Fs004280050226&volume=433&pages=119-129&publication_year=1998&author=Malzahn%2CK&author=Mitze%2CM&author=Thoenes%2CM
- https://doi.org/10.1016%2FS0002-9440%2810%2964476-8's revenue stream
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12466114 earns monthly
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20cytokeratins%2017%20and%205%20identifies%20a%20group%20of%20breast%20carcinomas%20with%20poor%20clinical%20outcome&journal=Am%20J%20Pathol&doi=10.1016%2FS0002-9440%2810%2964476-8&volume=161&pages=1991-1996&publication_year=2002&author=Rijn%2CM&author=Perou%2CCM&author=Tibshirani%2CR?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8823339 earn?
- How much does http://scholar.google.com/scholar_lookup?&title=Loss%20of%20estrogen%20receptor%20in%20recurrent%20breast%20cancer%20is%20associated%20with%20poor%20response%20to%20endocrine%20therapy&journal=J%20Clin%20Oncol&volume=14&pages=2584-2589&publication_year=1996&author=Kuukasjarvi%2CT&author=Kononen%2CJ&author=Helin%2CH generate monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1450062 make?
- http://scholar.google.com/scholar_lookup?&title=Sequential%20estrogen%20receptor%20determinations%20from%20primary%20breast%20cancer%20and%20at%20relapse%3A%20prognostic%20and%20therapeutic%20relevance.%20The%20international%20breast%20cancer%20study%20group%20%28formerly%20Ludwig%20group%29&journal=Ann%20Oncol&volume=3&pages=733-740&publication_year=1992&author=Spataro%2CV&author=Price%2CK&author=Goldhirsch%2CA's revenue stream
- Income figures for https://doi.org/10.1073/pnas.0905718106
- How much money does https://doi.org/10.1073%2Fpnas.0905718106 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19666588 earn?
- http://scholar.google.com/scholar_lookup?&title=Residual%20breast%20cancers%20after%20conventional%20therapy%20display%20mesenchymal%20as%20well%20as%20tumor-initiating%20features&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0905718106&volume=106&pages=13820-13825&publication_year=2009&author=Creighton%2CCJ&author=Li%2CX&author=Landis%2CM's total income per month
- Get to know https://doi.org/10.1158/0008-5472.CAN-08-1404's earnings
- Get to know https://doi.org/10.1158%2F0008-5472.CAN-08-1404's earnings
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18794137's financial summary
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Development%20of%20resistance%20to%20targeted%20therapies%20transforms%20the%20clinically%20associated%20molecular%20profile%20subtype%20of%20breast%20tumor%20xenografts&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-1404&volume=68&pages=7493-7501&publication_year=2008&author=Creighton%2CCJ&author=Massarweh%2CS&author=Huang%2CS bring in?
- Monthly income for https://doi.org/10.1158/0008-5472.CAN-07-2707
- How much money does https://doi.org/10.1158%2F0008-5472.CAN-07-2707 make?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18245484?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Tamoxifen%20resistance%20in%20breast%20tumors%20is%20driven%20by%20growth%20factor%20receptor%20signaling%20with%20repression%20of%20classic%20estrogen%20receptor%20genomic%20function&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-07-2707&volume=68&pages=826-833&publication_year=2008&author=Massarweh%2CS&author=Osborne%2CCK&author=Creighton%2CCJ?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9371488 makes per month
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Dissociation%20between%20steroid%20receptor%20expression%20and%20cell%20proliferation%20in%20the%20human%20breast&journal=Cancer%20Res&volume=57&pages=4987-4991&publication_year=1997&author=Clarke%2CRB&author=Howell%2CA&author=Potten%2CCS?
- How much does https://doi.org/10.1093/annonc/mdp263 earn?
- Revenue of https://doi.org/10.1093%2Fannonc%2Fmdp263
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19596702 rake in every month?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Prognostic%20impact%20of%20discordance%20between%20triple-receptor%20measurements%20in%20primary%20and%20recurrent%20breast%20cancer&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdp263&volume=20&pages=1953-1958&publication_year=2009&author=Liedtke%2CC&author=Broglio%2CK&author=Moulder%2CS?
- Financial intake of https://doi.org/10.1634/theoncologist.2008-0048
- What's the income of https://doi.org/10.1634%2Ftheoncologist.2008-0048?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18650259's total income per month
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Comparison%20of%20her-2%20and%20hormone%20receptor%20expression%20in%20primary%20breast%20cancers%20and%20asynchronous%20paired%20metastases%3A%20impact%20on%20patient%20management&journal=Oncologist&doi=10.1634%2Ftheoncologist.2008-0048&volume=13&pages=838-844&publication_year=2008&author=Guarneri%2CV&author=Giovannelli%2CS&author=Ficarra%2CG?
- What's the financial gain of https://doi.org/10.1016/j.cell.2009.06.034?
- Learn how profitable https://doi.org/10.1016%2Fj.cell.2009.06.034 is on a monthly basis
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19682730?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Identification%20of%20selective%20inhibitors%20of%20cancer%20stem%20cells%20by%20high-throughput%20screening&journal=Cell&doi=10.1016%2Fj.cell.2009.06.034&volume=138&pages=645-659&publication_year=2009&author=Gupta%2CPB&author=Onder%2CTT&author=Jiang%2CG?
- https://citation-needed.springer.com/v2/references/10.1007/s10549-010-1078-6?format=refman&flavour=references's total income per month
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Peter%20Kabos?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Peter%20Kabos%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=James%20M.%20Haughian?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22James%20M.%20Haughian%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xinshuo%20Wang earning monthly?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xinshuo%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wendy%20W.%20Dye pull in?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wendy%20W.%20Dye%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christina%20Finlayson?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christina%20Finlayson%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anthony%20Elias earn?
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anthony%20Elias%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kathryn%20B.%20Horwitz earning monthly?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kathryn%20B.%20Horwitz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carol%20A.%20Sartorius makes per month
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carol%20A.%20Sartorius%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://s100.copyright.com/AppDispatchServlet?title=Cytokeratin%205%20positive%20cells%20represent%20a%20steroid%20receptor%20negative%20and%20therapy%20resistant%20subpopulation%20in%20luminal%20breast%20cancers&author=Peter%20Kabos%20et%20al&contentID=10.1007%2Fs10549-010-1078-6©right=Springer%20Science%2BBusiness%20Media%2C%20LLC.&publication=0167-6806&publicationDate=2010-07-28&publisherName=SpringerNature&orderBeanReset=true make?
- What are the earnings of https://citation-needed.springer.com/v2/references/10.1007/s10549-010-1078-6?format=refman&flavour=citation?
- Get to know https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's earnings
- Monthly income for https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- Earnings of https://www.springernature.com/gp/products
- What's the financial gain of https://www.springernature.com/gp/librarians?
- How profitable is https://www.springernature.com/gp/societies?
- How much profit is https://www.springernature.com/gp/partners making per month?
- What are the earnings of https://www.springer.com/?
- Get to know what's the income of https://www.nature.com/
- How much does https://www.biomedcentral.com/ gross monthly?
- Discover the revenue of https://www.palgrave.com/
- Explore the financials of https://www.apress.com/
- What's the income generated by https://www.springernature.com/gp/legal/ccpa each month?
- Monthly income for https://www.springernature.com/gp/info/accessibility
- What's the financial gain of https://support.springernature.com/en/support/home?
- Learn about the earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- Explore the financials of https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref